214 related articles for article (PubMed ID: 38564687)
1. Differential impacts of DNA repair machinery on fluoroquinolone persisters with different chromosome abundances.
Tang J; Herzfeld AM; Leon G; Brynildsen MP
mBio; 2024 May; 15(5):e0037424. PubMed ID: 38564687
[TBL] [Abstract][Full Text] [Related]
2. Ploidy is an important determinant of fluoroquinolone persister survival.
Murawski AM; Brynildsen MP
Curr Biol; 2021 May; 31(10):2039-2050.e7. PubMed ID: 33711253
[TBL] [Abstract][Full Text] [Related]
3. Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery.
Völzing KG; Brynildsen MP
mBio; 2015 Sep; 6(5):e00731-15. PubMed ID: 26330511
[TBL] [Abstract][Full Text] [Related]
4. Timing of DNA damage responses impacts persistence to fluoroquinolones.
Mok WWK; Brynildsen MP
Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6301-E6309. PubMed ID: 29915065
[TBL] [Abstract][Full Text] [Related]
5. Tolerance of Escherichia coli to fluoroquinolone antibiotics depends on specific components of the SOS response pathway.
Theodore A; Lewis K; Vulic M
Genetics; 2013 Dec; 195(4):1265-76. PubMed ID: 24077306
[TBL] [Abstract][Full Text] [Related]
6. The AcrAB-TolC Efflux Pump Impacts Persistence and Resistance Development in Stationary-Phase Escherichia coli following Delafloxacin Treatment.
Byrd BA; Zenick B; Rocha-Granados MC; Englander HE; Hare PJ; LaGree TJ; DeMarco AM; Mok WWK
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0028121. PubMed ID: 34097492
[TBL] [Abstract][Full Text] [Related]
7. Toxin Induction or Inhibition of Transcription or Translation Posttreatment Increases Persistence to Fluoroquinolones.
Lemma AS; Brynildsen MP
mBio; 2021 Aug; 12(4):e0198321. PubMed ID: 34399616
[TBL] [Abstract][Full Text] [Related]
8. Role of oxidative stress in persister tolerance.
Wu Y; Vulić M; Keren I; Lewis K
Antimicrob Agents Chemother; 2012 Sep; 56(9):4922-6. PubMed ID: 22777047
[TBL] [Abstract][Full Text] [Related]
9. Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment.
Hare PJ; Englander HE; Mok WWK
J Appl Microbiol; 2022 Jun; 132(6):4020-4032. PubMed ID: 35332984
[TBL] [Abstract][Full Text] [Related]
10. Identification of Novel Genes Involved in
Li T; Wang J; Cao Q; Li F; Han J; Zhu B; Zhang Y; Niu H
Front Cell Infect Microbiol; 2020; 10():581986. PubMed ID: 33117736
[TBL] [Abstract][Full Text] [Related]
11. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide mapping of fluoroquinolone-stabilized DNA gyrase cleavage sites displays drug specific effects that correlate with bacterial persistence.
Tang J; Brynildsen MP
Nucleic Acids Res; 2023 Feb; 51(3):1208-1228. PubMed ID: 36631985
[TBL] [Abstract][Full Text] [Related]
13. Host Cell Oxidative Stress Promotes Intracellular Fluoroquinolone Persisters of Streptococcus pneumoniae.
Hernandez-Morfa M; Reinoso-Vizcaíno NM; Olivero NB; Zappia VE; Cortes PR; Jaime A; Echenique J
Microbiol Spectr; 2022 Dec; 10(6):e0436422. PubMed ID: 36445159
[TBL] [Abstract][Full Text] [Related]
14. Transcription-coupled DNA repair underlies variation in persister awakening and the emergence of resistance.
Wilmaerts D; Focant C; Matthay P; Michiels J
Cell Rep; 2022 Mar; 38(9):110427. PubMed ID: 35235801
[TBL] [Abstract][Full Text] [Related]
15. Specific Enrichment and Proteomics Analysis of Escherichia coli Persisters from Rifampin Pretreatment.
Sulaiman JE; Hao C; Lam H
J Proteome Res; 2018 Nov; 17(11):3984-3996. PubMed ID: 30336045
[TBL] [Abstract][Full Text] [Related]
16. Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition.
Aedo SJ; Orman MA; Brynildsen MP
BMC Microbiol; 2019 Jun; 19(1):140. PubMed ID: 31234796
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic persistence: the role of spontaneous DNA repair response.
Debbia EA; Roveta S; Schito AM; Gualco L; Marchese A
Microb Drug Resist; 2001; 7(4):335-42. PubMed ID: 11822773
[TBL] [Abstract][Full Text] [Related]
18. RNA Futile Cycling in Model Persisters Derived from MazF Accumulation.
Mok WW; Park JO; Rabinowitz JD; Brynildsen MP
mBio; 2015 Nov; 6(6):e01588-15. PubMed ID: 26578677
[TBL] [Abstract][Full Text] [Related]
19. (p)ppGpp-Dependent Persisters Increase the Fitness of Escherichia coli Bacteria Deficient in Isoaspartyl Protein Repair.
VandenBerg KE; Ahn S; Visick JE
Appl Environ Microbiol; 2016 Sep; 82(17):5444-54. PubMed ID: 27371580
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic.
Barrett TC; Mok WWK; Murawski AM; Brynildsen MP
Nat Commun; 2019 Mar; 10(1):1177. PubMed ID: 30862812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
